Pending home sales in the U.S. fell 3.5% week-over-week to their lowest level in almost three years, signaling reduced buyer demand and less competition. Despite a slight decline in new listings, inventory remains higher than last year, giving buyers more choices and negotiating power. Home prices remain stable with a 2% year-over-year increase, while sellers adjust expectations amid high mortgage rates. This market environment favors buyers who can afford to wait, as lower mortgage rates could quickly deplete inventory and reignite bidding wars.
Redfin's report on U.S. pending home sales comes with Pluang market data as of Sep 17, 2026 17:11 WIB. For readers following Real Estate-sector stocks, 14 of 22 priced US stocks rose while 4 fell. Notable movers include PLD at USD 134.35 with a 0.44% increase and 100% buy order activity, O at USD 57.39 with a 0.42% rise and a 55% buy order activity, and OPEN at USD 2.60 with a 0.39% gain despite 82% sell order activity. The most notable figure is PLD's full buy-side order activity on Pluang.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
